You are here

Article Text

Article menu
Learning from errors
Rhabdomyolysis caused by an interaction of simvastatin and fusidic acid
  1. Roselle Herring,
  2. Gordon Caldwell,
  3. Stuart Wade
  1. Worthing and Southlands NHS Trust, Endocrine and Diabetes, Worthing Hospital, Lyndhurst Road, West Sussex, BN11 2DH, UK
  1. Roselle Herring, roselle.herring1{at}btinternet.com

Summary

A case of severe rhabdomyolysis caused by an interaction between fusidic acid and simvastatin is described. Fusidic acid significantly reduces the excretion of simvastatin resulting in increased plasma levels thereby increasing the side effect profile. Simvastatin treatment should be temporarily withheld during treatment with fusidic acid.

https://doi.org/10.1136/bcr.03.2009.1722

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests: None.

    • Patient consent: Patient/guardian consent was obtained for publication.